PTHS

Pelthos Therapeutics
PTHS

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $846K invested in Pelthos Therapeutics in 2025 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$626K
2
+$186K
3
+$14.3K
4
TRCT
Tower Research Capital (TRC)
New York
+$3.29K
5
UBS Group
UBS Group
Switzerland
+$1.41K

Top Sellers

1
-$9.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
IC
1
Ikarian Capital
Texas
$626K
BFM
2
Boothbay Fund Management
New York
$186K
Wealth Enhancement Advisory Services
3
Wealth Enhancement Advisory Services
Minnesota
$14.8K
Geode Capital Management
4
Geode Capital Management
Massachusetts
$14.3K
TRCT
5
Tower Research Capital (TRC)
New York
$3.64K
UBS Group
6
UBS Group
Switzerland
$1.41K
TCM
7
Tradewinds Capital Management
Washington
$284
Bank of America
8
Bank of America
North Carolina
$17
TSS
9
Two Sigma Securities
New York
–